Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kluger, HM; Halabi, S; Solomon, NC; Jilaveanu, L; Zito, C; Sznol, J; Nixon, AB; Rini, BI; Small, EJ; George, DJ

Published Date

  • May 20, 2014

Published In

Volume / Issue

  • 32 / 15_suppl

Start / End Page

  • 4532 - 4532

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2014.32.15_suppl.4532